Parcopa and Chest pain - a phase IV clinical study of FDA data

Summary:

Chest pain is reported as a side effect among people who take Parcopa (carbidopa; levodopa), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Sinemet, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Chest pain when taking Parcopa. It is created by eHealthMe based on reports of 230 people who have side effects when taking Parcopa from the FDA, and is updated regularly.

What is Parcopa?

Parcopa has active ingredients of carbidopa; levodopa. eHealthMe is studying from 234 Parcopa users. Check the latest studies of Parcopa.

What is Chest pain?

Chest pain is found to be associated with 3,458 drugs and 4,889 conditions by eHealthMe. Check the latest studies of Chest pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

230 people reported to have side effects when taking Parcopa.
Among them, 13 people (5.65%) have Chest pain.

Among these 13 people:

How long have people been on Parcopa when they have Chest pain? *

What is the gender of people who have Chest pain when taking Parcopa? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Chest pain when taking Parcopa? *

What are other drugs people take besides Parcopa? *

What are other side effects people have besides Chest pain? *

Hyperhidrosis (abnormally increased sweating): 7 people, 53.85%
Weakness: 6 people, 46.15%
Hypotension (abnormally low blood pressure): 6 people, 46.15%
Fever: 4 people, 30.77%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 4 people, 30.77%
Headache (pain in head): 4 people, 30.77%
Rashes (redness): 4 people, 30.77%
Aggression: 4 people, 30.77%
Throat Tightness: 3 people, 23.08%
Memory Loss: 3 people, 23.08%

What are the existing conditions these people have? *

Parkinson's Disease: 13 people, 100.00%
High Blood Pressure: 3 people, 23.08%
Depression: 3 people, 23.08%
Dermal Cyst: 2 people, 15.38%
Colitis Microscopic (inflammation of colon with diarrhoea and abdominal cramps): 2 people, 15.38%
Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Parcopa and have Chest pain?

- Check whether Chest pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Parcopa:

Parcopa (234 reports)

Chest pain treatments and more:

Chest pain (363,502 reports)

Browse all side effects of Parcopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chest pain:

Chest pain (3,458 drugs)

Browse all the conditions that are associated with Chest pain:

Chest pain (4,889 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on carbidopa; levodopa (the active ingredients of Parcopa) and Parcopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.